A recent study published in the British Medical Journal has revealed the significant benefits of COVID-19 vaccines in reducing the risk of heart failure and blood clots following COVID infection. The study, which looked at data from over 20 million people in Europe, found that vaccination can reduce the risk of heart failure by up to 55% and blood clots by up to 78%.
Dr. John Brownstein, chief innovation officer at Boston Children’s Hospital, emphasized that the risk of complications from vaccination is actually higher when one contracts the SARS-CoV-2 infection itself. The positive health effects of the vaccines were found to last for up to a year, with more pronounced effects seen immediately after vaccination.
The research also showed that within a month of receiving the COVID vaccine, the risk of blood clots in veins decreased by 78%, blood clots in arteries by 47%, and heart failure by 55%. Over a six-month period, the risk of a blood clot in the vein was reduced by 47%, in the artery by 28%, and heart failure by 39%.
In response to these findings, the U.S. Centers for Disease Control and Prevention (CDC) has approved an updated COVID-19 vaccine for adults over 65 to provide further protection against severe hospitalization and death. Researchers concluded that COVID-19 vaccines play a crucial role in reducing the risk of long-term health complications following infection.
This study highlights the importance of vaccination in combatting the harmful effects of COVID-19 and protecting public health on a global scale.
“Travel aficionado. Incurable bacon specialist. Tv evangelist. Wannabe internet enthusiast. Typical creator.”